68.27USD-0.18%Mkt Cap: 2.93B $P/E: —1d ago
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individ…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/B
Cheaper
1M Perf
Higher
$186.32BUSDP/E 27.6
$134.82BUSDP/E 36.8
$43.51BUSDP/E 42.0
$41.53BUSDP/E 38.7
$38.88BUSD
$37.53BUSDP/E 26.7
$36.82BUSDP/E 47.7
$32.25BUSDP/E 24.0
$26.60BUSDP/E 31.9
$25.82BUSDP/E 30.0
$23.46BUSDP/E 23.4
$22.96BUSDP/E 24.8
$19.89BUSD
$15.12BUSDP/E 33.3
$12.91BUSDP/E 26.9
$12.41BUSDP/E 53.5
$10.92BUSD
$8.81BUSDP/E 20.6
$6.41BUSD
$5.52BUSDP/E 222.2
$5.06BUSDP/E 43.3
$4.85BUSD
$4.69BUSDP/E 54.4
$3.65BUSDP/E 25.7
$3.43BUSD
$2.04BUSD
$1.90BUSD
$1.48BUSDP/E 37.4
$1.48BUSDP/E 22.4
$1.47BUSD
$1.40BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$723.37MUSD
$615.20MUSDP/E 40.1
$582.78MUSD
$539.30MUSD
$297.38MUSDP/E 3.0
$282.06MUSD
$233.52MUSD
$190.51MUSD
$147.80MUSD
$112.34MUSD
$94.30MUSDP/E 18.2
$77.88MUSD
$58.94MUSD
$44.26MUSD
$27.97MUSD
$27.15MUSD
$22.69MUSD
$17.60MUSD
$12.55MUSD
$10.07MUSDP/E 63.2
$9.85MUSD
$9.02MUSD
$8.78MUSD
$6.77MUSD
$6.29MUSD
$5.98MUSD
$5.10MUSD
$4.66MUSD
$3.81MUSD
$3.86MUSDP/E 2.8
$2.93MUSD
$2.79MUSD
$2.43MUSD
$1.29MUSD
$314.2KUSDP/E Infinity
$14.0KUSD
Indicators:|
Key Statistics
Company
Market Cap2.93B $
Enterprise Value2.16B $
Revenue (TTM)156.12M $
Gross Profit-62.57M $
Net Income (TTM)-408.35M $
Revenue/Share4.072 USD
Last Price68.27 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees910
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.02
PEG—
EV/EBITDA-5.99
EV/Revenue13.82
P/S18.77
P/B1.12
EPS (TTM)-10.30
EPS (Forward)-9.72
52W Range
29.9543% of range118.84
52W High118.84 USD
52W Low29.95 USD
Profitability
Gross Margin-42.52%
Oper. Margin-332.88%
EBITDA Margin-230.91%
Profit Margin-277.47%
ROE-15.84%
ROA-13.97%
Growth
Revenue Growth28.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-299.01M $
CapEx (TTM)909.00K $
FCF Margin-69.02%
FCF Yield-3.68%
Net Debt-772.08M $
Net Debt/EBITDA2.14
Balance Sheet
Debt/Equity0.02
Current Ratio11.74
Quick Ratio11.29
Book Value/Sh60.79 USD
Cash/Share19.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)66.00 USD
Upside (mean)-3.3%
Target Range56.00 USD – 80.00 USD
$56.00-3.3% to mean$80.00
# Analysts8
Ownership
Shares Out.42.92M
Float33.53M
Insiders5.23%
Institutions83.51%
Short Interest
Short Ratio8.4d
Short % Float16.83%
Short % Out.16.56%
Shares Short7.10M
Short (prev mo.)7.15M
Technical
SMA 5060.63 (+12.6%)
SMA 20072.33 (-5.6%)
Beta3.16
S&P 52W Chg20.05%
Avg Vol (30d)681.38K
Avg Vol (10d)734.18K
Technical Indicators
RSI (14)59.8
MACD1.3889
MACD Signal0.7033
MACD Hist.+0.6857
BB Upper68.83 USD
BB Middle62.35 USD
BB Lower55.87 USD
BB Width20.79%
ATR (14)4.378 USD
Vol Ratio (20d)0.49x